A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment

Internal tandem duplication mutations of the FMS-like tyrosine kinase-3 (FLT3-ITDs) occur in 25%–30% of patients with acute myeloid leukemia (AML) and are associated with dismal prognosis. Although FLT3 inhibitors have demonstrated initial clinical efficacy, the overall outcome of patients with FLT3...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Jun, Chen, Xinjie, Shen, Yan, Lei, Yichen, Mu, Lili, Wang, Zhen, Xiang, Rufang, Gao, Wenhui, Wang, Lining, Wang, Ling, Jiang, Jieling, Zhang, Wenjun, Lu, Huina, Dong, Yan, Ding, Yi, Zhu, Honghu, Hong, Dengli, Sun, Yi Eve, Hu, Jiong, Liang, Aibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694671/
https://www.ncbi.nlm.nih.gov/pubmed/37951217
http://dx.doi.org/10.1016/j.xcrm.2023.101286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694671/
https://www.ncbi.nlm.nih.gov/pubmed/37951217
http://dx.doi.org/10.1016/j.xcrm.2023.101286

Ejemplares similares